https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Sebetralstat Becomes First and Only FDA-Approved Oral, On-Demand Treatment for HAE

Sebetralstat Becomes First and Only FDA-Approved Oral, On-Demand Treatment for HAE

Sebetralstat becomes the first FDA-approved oral treatment for hereditary angioedema (HAE), offering rapid relief for patients experiencing acute attacks.

administrator

Related Articles